[ Special series on U ]
doi: 10.1186/s40880-017-0194-7
Ailanthone: a new potential drug for castration-resistant prostate cancer
Shihong Peng, Zhengfang Yi and Mingyao Liu
East China Normal University and Shanghai Fengxian District Central Hospital Joint Center for Translational Medicine, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University
Chinese Journal of Cancer 2017, Volume: 36, Issue 5
[ PDF Full-text ]
[ Html full-text / Citation export] (BioMed Central)
[Google Scholar]
[ More articles of the special series on U ]
Cite this article
Shihong Peng, Zhengfang Yi and Mingyao Liu. Ailanthone: a new potential drug for castration-resistant prostate cancer. Chin J Cancer. 2017, 36:25. doi:10.1186/s40880-017-0194-7
Export citations
EndNote
[ Html full-text / Citation export] (BioMed Central)
[Google Scholar]
[ More articles of the special series on U ]
Cite this article
Shihong Peng, Zhengfang Yi and Mingyao Liu. Ailanthone: a new potential drug for castration-resistant prostate cancer. Chin J Cancer. 2017, 36:25. doi:10.1186/s40880-017-0194-7
Export citations
EndNote
SHARE THIS ARTICLE
Comments:
